Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05148559 · ClinicalTrials.gov registry record · NA
Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination
A NA study of Papillomavirus Vaccines, sponsored by Huong Nguyen, PhD.
- Active
- Registry status
- NA
- Development phase
- 5,451
- Enrollment target
- 1
- Study location
NCT05148559 is a NA study of Papillomavirus Vaccines that is active but no longer recruiting, run by Huong Nguyen, PhD. The registered enrollment target is 5,451 participants, above the 2,549-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (114% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05148559, a NA study of Papillomavirus Vaccines, is active but no longer recruiting, sponsored by Huong Nguyen, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5,451 participants
- Enrollment target
- 1
- Study location
Study Summary
Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of communication on HPV vaccination among 12 year-old patients in a regional healthcare system.
Conditions Studied
Interventions
- BEHAVIORAL Reminder Sent Via Preferred Method of Communication
- BEHAVIORAL Reminder Sent Via Mailed Letter
Study Locations (1)
Wisconsin
- Marshfield Clinic Health System - Marshfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,451 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05148559
The ClinicalTrials.gov registry entry for NCT05148559 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5,451 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,549-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (114% higher). The listed sponsor is Huong Nguyen, PhD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Papillomavirus Vaccines appearing as the primary indexed condition, and to 2 interventions - of which Reminder Sent Via Preferred Method of Communication is the first listed.
NCT05148559 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05148559 about?
NCT05148559 is a clinical study titled "Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination". Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of com...
What is the current status of trial NCT05148559?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5,451 participants. The study started on 2021-08-12. Estimated completion is 2026-12.
What conditions does trial NCT05148559 study?
This clinical trial studies the following conditions: Papillomavirus Vaccines.
What interventions are being tested in trial NCT05148559?
The interventions under investigation include: Reminder Sent Via Preferred Method of Communication (BEHAVIORAL), Reminder Sent Via Mailed Letter (BEHAVIORAL).
Who is sponsoring clinical trial NCT05148559?
This trial is sponsored by Huong Nguyen, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05148559 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papillomavirus Vaccines
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
RECRUITING · NA
-
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
Let's K-Talk - HPV Study for Ethnic Koreans
ACTIVE NOT RECRUITING · NA
-
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.